Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
199 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Greenslopes Private Hospital
Greenslopes, Queensland, Australia
- St. John of God Murdoch Hospital
Murdoch, Western Australia, Australia
- Monash Medical Centre
Clayton, Australia
- Sydney Adventist Hospital
Wahroonga, Australia
- Westmead Hosptial
Westmead, Australia
- Klinikum Klagenfurt Am Wörthersee
Klagenfurt, Wörthersee, Austria
- Medical University Graz
Graz, Austria
- Univ. Klinik Für Innere Medizin Iii Der Pmu
Salzburg, Austria
- Landes-Krankenhaus Steyr
Steyr, Austria
- Faculté de Médecine Campus Erasme
Anderlecht, Belgium
- Uz Leuven
Leuven, Belgium
- Clinique Universutaire Saint Luc - Institut Roi Albert Ii
Woluwe-Saint-Lambert, Belgium
- Centro de Pesquisa Clínica E Ensino Florianópolis Ltda
Florianópolis, Brazil
- Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda
Ijuí, Brazil
- Hospital São Lucas Da Pucrs
Porto Alegre, Brazil
- Hospital de Clínicas de Porto Alegre
Porto Alegre, Brazil
- Irmandade Da Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, Brazil
- Irpcc - Instituto Ribeirãopretano de Combate Ao Câncer
Ribeirão Preto, Brazil
- Groupo Clinicas Oncologicas Integradas (coi) - Barra Da Tijuca
Rio de Janeiro, Brazil
- Instituto D'Or de Pesquisa E Ensino - Rio de Janeiro
Rio de Janeiro, Brazil
- Oncoclinicas Group Botafogo
Rio de Janeiro, Brazil
- Instituto D´or de Pesquisa E Ensino - Hospital São Rafael
São Marcos, Brazil
- Clínica Oncostar - Rede D´or
São Paulo, Brazil
- Núcleo de Pesquisa Clínica Da Rede São Camilo
São Paulo, Brazil
- London Regional Cancer Program, London Health Sciences Centre
London, Ontario, Canada
- Centre Hospitalier de I'Universitaire de de Montreal (chum)
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke Ciusss de L'Estrie - Chus
Sherbrooke, Quebec, Canada
- Sun Yat-Sen Memorial Hospital Sun Yat-Sen University
Guangzhou, Guangdong, China
- Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
- Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
- Union Hospital Affiliated To Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
- the First Affiliated Hospital of Xi 'An Jiaotong University
Xi'an, Shaanxi, China
- Linyi Cancer Hospital
Linyi, Shandong, China
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
- Beijing Cancer Hospital
Beijing, China
- Peking Union Medical College Hospital
Beijing, China
- Peking University People'S Hospital
Beijing, China
- the First Hospital of Jilin University
Changchun, China
- Guangdong Provincial People'S Hospital
Guangzhou, China
- Jilin Guowen Hospital
Jilin City, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 May 2018
- Primary completion
- 16 Oct 2024
- Completion
- 16 Oct 2024
- Last update posted
- 21 Jan 2026
- Registered enrollment
- 571
- Registry id
- NCT03377491
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.